Neuropsychopharmacology
- Dorsal raphe to basolateral amygdala corticotropin-releasing factor circuit regulates cocaine-memory reconsolidation2 years ago
- Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial2 years ago
- A neural pathway integrating stress and feeding2 years ago
- Placebo response in RCT for antidepressant may not always be the ‘villain’ to fight: are KOR antagonists possibly affecting the intrinsic placebo response?2 years ago
- Resting state functional brain connectivity in child and adolescent psychiatry: where are we now?2 years ago
- Parvalbumin interneuron mGlu5 receptors govern sex differences in prefrontal cortex physiology and binge drinking2 years ago
- Endocannabinoids and related lipids linked to social exclusion in individuals with chronic non-medical prescription opioid use2 years ago
Journal of Psychopharmacology
- Clozapine and the aryl hydrocarbon receptor4 years ago
- The effect of metformin on cognitive function: A systematic review and meta-analysis4 years ago
- Glutamate levels across deep brain structures in patients with a psychotic disorder and its relation to cognitive functioning4 years ago
- Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ)4 years ago
- The effects of intranasal esketamine on on-road driving performance in patients with major depressive disorder or persistent depressive disorder4 years ago
- Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine4 years ago
- A randomized controlled trial of 3,4-methylenedioxymethamphetamine (MDMA) and fear extinction retention in healthy adults4 years ago
European Neuropsychopharmacology
- A polygenic-informed approach to a predictive EEG signature empowers antidepressant treatment prediction: A proof-of-concept study4 years ago
- Associations between oxidative stress markers and patient-reported smartphone-based symptoms in patients newly diagnosed with bipolar disorder: An exploratory study4 years ago
- The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders4 years ago
- New antidepressants: New day or false dawn?4 years ago
- Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism4 years ago
- Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment4 years ago
- Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder4 years ago